A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 48.8 KBAnacor Pharmaceuticals, Inc.Jan 5, 9:33 PM ET·0001209191-16-089486
- 49.1 KBAnacor Pharmaceuticals, Inc.Jan 5, 9:31 PM ET·0001209191-16-089485
- 49.0 KBAnacor Pharmaceuticals, Inc.Jan 5, 9:30 PM ET·0001209191-16-089483
- 419.3 KBAnacor Pharmaceuticals, Inc.Apr 28, 8:37 PM ET·0001209191-15-036806
- 45.1 KBAnacor Pharmaceuticals, Inc.Jan 6, 4:27 PM ET·0001209191-15-002196
- 45.0 KBAnacor Pharmaceuticals, Inc.Jan 6, 4:25 PM ET·0001209191-15-002191
- SC 13G8.4 KBAnacor Pharmaceuticals, Inc.Jan 6, 1:35 PM ET·0000790502-15-000008
- 45.6 KBAnacor Pharmaceuticals, Inc.Feb 10, 7:38 PM ET·0001209191-14-008844
- 48.6 KBAnacor Pharmaceuticals, Inc.Jan 9, 6:27 PM ET·0001209191-14-002700
- 46.5 KBAnacor Pharmaceuticals, Inc.Jun 19, 6:43 PM ET·0001209191-13-033044
Insiders
10- BERNS PAUL LDirector, President and CEO
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Heyman Irwin ASenior VP, Drug Development
- Hove Anders DDirector, 10% Owner
- IPPOLITO VINCENT PEVP & Chief Commercial Officer
- LESCHLY MARKDirector, 10% Owner
- Maples Kirk RSVP, Program Management
- Markham Richard JDirector
- Parker Geoffrey M.Sr. V.P. & CFO
- Plattner Jacob jSenior VP, Research
Tickers
No tickers on record
Addresses
business
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
mailing
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
Former Names
- Anacor Pharmaceuticals Inc2013-04-08